Spatial profiling of non-small cell lung cancer provides insights into tumorigenesis and immunotherapy response

Patient characteristics

Spatial transcriptome analysis was conducted on the lung tissues obtained from 18 patients with stage IV NSCLC who were candidates for immune checkpoint blockade. The clinical characteristics of the patients are summarized in Table 1.